News & Updates

Show Multimedia Only

Fish oil plus low-dose isotretinoin shows promise as acne vulgaris therapy

27 Jul 2026

The combination of fish oil supplementation and low-dose isotretinoin demonstrates noninferiority to isotretinoin monotherapy and keeps the skin hydrated in patients with moderate-to-severe acne vulgaris, reports a study. The combined treatment also helps control triglyceride levels.

Fish oil plus low-dose isotretinoin shows promise as acne vulgaris therapy

27 Jul 2026

Which anti-obesity drug is safest, most effective?

27 Jul 2026 by

Among available drugs for obesity, tirzepatide and cagrilintide-semaglutide (CagriSema) yield the largest decrease in body weight, regardless of diabetes status, suggest the results of a systematic review and network meta-analysis.

Which anti-obesity drug is safest, most effective?

27 Jul 2026

Cefdinir vs cephalexin: Which is a better step-down therapy in severe UTI?

27 Jul 2026

Treatment with cefdinir and cephalexin results in comparable failure rates, but patients on cephalexin tend to have more unplanned clinic and emergency visits, a study has shown.

Cefdinir vs cephalexin: Which is a better step-down therapy in severe UTI?

27 Jul 2026

Adjunctive speleotherapy may be beneficial in long COVID

27 Jul 2026 by

Speleotherapy, or underground climate therapy, may benefit individuals with chronic respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), or long COVID, a study suggests.

Adjunctive speleotherapy may be beneficial in long COVID

27 Jul 2026

Singapore Specialists Discuss RSV Prevention Strategies

27 Jul 2026

Two experts in their field, Dr Shephali Tagore and Clinical Associate Professor Yung Chee Fu, share their perspectives on maternal respiratory syncytial virus (RSV) immunisation, parental awareness gaps, and the practical realities of integrating prevention into clinical care pathways.

Singapore Specialists Discuss RSV Prevention Strategies

27 Jul 2026

Trust in AI-enabled care begins with clear, informed consent

27 Jul 2026 by

The growing use of artificial intelligence (AI) tools in clinical settings is transforming how care is delivered and bringing benefits to healthcare professionals (HCPs) and their patients.

Trust in AI-enabled care begins with clear, informed consent

27 Jul 2026

Original New Drug Application Approvals by US FDA (1-15 July 2026)

27 Jul 2026

New drug applications approved by US FDA as of 1-15 July 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 July 2026)

27 Jul 2026

Buprenorphine a viable option for acute pain in ICU patients

26 Jul 2026

The use of intravenous (IV) buprenorphine appears to be a good substitute for full agonist IV opioids for managing pain in the medical intensive care unit (ICU), suggests a study.